About myTomorrows
myTomorrows is a company based in Amsterdam (Netherlands) founded in 2012 by Ronald Brus. myTomorrows has raised $51.3 million across 5 funding rounds from investors including Balderton Capital, EQT Ventures and Octopus Ventures. myTomorrows operates in a competitive market with competitors including Evidation, Antidote, Dyania Health, SubjectWell and Clara Health, among others.
- Headquarter Amsterdam, Netherlands
- Founders Ronald Brus
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$51.3 M (USD)
in 5 rounds
-
Latest Funding Round
$29 M (USD), Series C
Nov 11, 2025
-
Investors
Balderton Capital
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of myTomorrows
Unlock access to complete
Funding Insights of myTomorrows
myTomorrows has successfully raised a total of $51.3M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $29 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in myTomorrows
myTomorrows has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Balderton Capital, EQT Ventures and Octopus Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology and innovation sectors.
|
Locked | Locked | Locked | |
|
Venture capital investment and support for founders in technology and health sectors.
|
Locked | Locked | Locked | |
|
Multistage venture capital investments are focused on technology sectors.
|
Locked | Locked | Locked |
Investor details for myTomorrows
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by myTomorrows
Investment portfolio details for myTomorrows
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - myTomorrows
Detailed financials for myTomorrows
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mytomorrows Comparisons
Peer comparison for myTomorrows
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of myTomorrows
myTomorrows operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evidation, Antidote, Dyania Health, SubjectWell and Clara Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Real-world health data is provided for research and decisions.
|
|
| Locked | Locked | Locked |
Provider of search engine tool for patients to explore, understand and access clinical trials.
|
|
| Locked | Locked | Locked |
Patients for clinical trials are identified through a dedicated platform.
|
|
| Locked | Locked | Locked |
Clinical trials marketplace for patient recruitment solutions is provided.
|
|
| Locked | Locked | Locked |
Clinical trials are matched to patients via an online platform.
|
Detailed competitors of myTomorrows
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mytomorrows
Complete news archive for myTomorrows
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about myTomorrows
myTomorrows was founded in 2012.
myTomorrows is headquartered in Amsterdam, Netherlands.
Ronald Brus is the current CEO of myTomorrows. They have also founded this company.
myTomorrows is a funded company, having raised a total of $51.3M across 5 funding rounds to date.
myTomorrows was established in 2012 in Amsterdam, Netherlands, within the healthcare sector. A digital platform is maintained to link patients, physicians, and pharmaceutical firms. Details on medical conditions, ongoing clinical trials, and early access initiatives are shared through the service. Applications for experimental treatments are processed, while diagnostic kits are distributed to support clinical needs.
myTomorrows's top competitors include Evidation, Dyania Health and SubjectWell.
myTomorrows has 5 investors. Key investors include Balderton Capital, EQT Ventures, Octopus Ventures, Sofinnova, and Avego.